nonprofit logo

Cancer Genomics Consortium

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 273232063 ✦ Lafayette, LA ✦ Designated as a 501(c)(3)

Overview

What is Cancer Genomics Consortium?

The Cancer Genomics Consortium is a nonprofit organization situated in Lafayette, Louisiana. Their primary mission is to foster communication and cooperation among cancer cytogenomics laboratories, serving both research and diagnostic purposes. They achieve this goal through various means, including education and collaboration. The organization hosts an annual conference, attended by researchers, students, and the general public, to share knowledge and insights about cancer microarrays and their role in diagnosing, predicting, and treating cancer. The 2022 conference attracted approximately 458 attendees. The Cancer Genomics Consortium's activities contribute to the broader understanding and treatment of cancer, benefiting the medical community and patients alike.


Official website here: www.cancergenomics.org

Is Cancer Genomics Consortium legitimate?

Cancer Genomics Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cancer Genomics Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.cancergenomics.org

What is the mission statement of Cancer Genomics Consortium?

The Cancer Genomics Consortium's mission is centered around fostering cooperation among cancer cytogenomics laboratories. This collaboration is aimed at serving research, educational, and diagnostic purposes. The consortium organizes an annual conference, acting as a significant educational event for researchers, students, and the general public. The conference features keynote speakers, invited speakers, and presentations of submitted abstracts from members, attracting a substantial audience, such as the 458 attendees in 2022, to explore the utility of cancer microarrays in diagnosis, prognosis, and therapy for cancer.


Official website here: www.cancergenomics.org

Who is the CEO of Cancer Genomics Consortium?

Xinjie Xu Phd is the President of Cancer Genomics Consortium.


Official website here: www.cancergenomics.org

What is the revenue of Cancer Genomics Consortium?

Cancer Genomics Consortium's revenue in 2022 was $471,897.


Official website here: www.cancergenomics.org

Who are the executives of Cancer Genomics Consortium and what are their salaries?

Here are 11 key members and their salaries:

    Obi L Griffith Phd (President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Rashmi Kanagal-Shamanna Md Fcap (Vice President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Patricia Miron Phd Facmg (Vice President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Fady Mikhail Md Phd Facmg (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Xinjie Xu Phd Facmg (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Linda Baughn Phd (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jane Houldsworth Phd (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kilannin Krysiak Phd Facmg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Trevor Pugh Phd Facmg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Niroshi Senaratne Phd Facmg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Teresa Smolarek Phd Facmg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.cancergenomics.org

    Where can I find the form 990 for Cancer Genomics Consortium?

    The Cancer Genomics Consortium’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.cancergenomics.org

    Learn more at the official website: www.cancergenomics.org

    Mission Statement of Cancer Genomics Consortium

    The Cancer Genomics Consortium is dedicated to fostering cooperation and communication among laboratories specializing in cancer cytogenomics. This nonprofit organization's primary goal is to facilitate research, educational, and diagnostic endeavors within this field. By promoting collaboration, the Cancer Genomics Consortium aims to advance the understanding and treatment of cancer, leveraging the collective expertise and resources of its member laboratories.

    One of the key activities of the Cancer Genomics Consortium is hosting an annual conference. This event serves as a significant educational platform, attracting researchers, students, and the general public. The conference features keynote speakers, invited presenters, and abstracts submitted by members, offering attendees an opportunity to learn about the latest developments in cancer microarrays and their applications in diagnosis, prognosis, and therapy. The 2022 meeting, for instance, drew approximately 458 participants eager to delve into these topics.

    Impact

    This information is meant to be a general summary of Cancer Genomics Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.




    Wednesday, July 24, 2024

    The Cancer Genomics Consortium has significantly impacted the field of medical research by promoting communication and collaboration among cancer cytogenomics laboratories. By organizing an annual conference that serves as a primary educational event for researchers, students, and the general public, the consortium facilitates the sharing of cutting-edge advancements in cancer microarrays and their application in diagnosis, prognosis, and therapy for cancer. With approximately 458 attendees at the 2022 meeting, the consortium is actively contributing to advancements in cancer genomics and fostering a supportive community for professionals in the field.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $5,444
  • Program Service Revenue: $459,668
  • Gross Receipts: $471,897

    • Assets and Liabilities:
  • Total Assets: $534,562
  • Total Liabilities: $22,519
  • Net Assets: $512,043
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    Annual Mtg Registration

    Revenue

    $139,994

    Annual Mtg Support

    Revenue

    $281,500

    Membership Dues

    Revenue

    $38,174

    Organization Details

    Founding Year

    2010

    Principal Officer

    Xinjie Xu Phd

    Main Address

    201 Rue Beauregard STE 202, Lafayette, LA, 70508

    NTEE Category

    Code: H12 - Medical research

    If you are a representative of Cancer Genomics Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.